Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia
Titel:
Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia
Auteur:
Yoon, J.-H. Yhim, H.-Y. Kwak, J.-Y. Ahn, J.-S. Yang, D.-H. Lee, J.-J. Kim, S.-J. Kim, J.-S. Park, S.J. Choi, C.W. Eom, H.-S. Park, S.-K. Choi, S.-Y. Kim, S.-H. Kim, D.-W. Lee, S.